Search results for "cnv"

showing 10 items of 21 documents

A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV.

2014

AIMS: The aim was to compare the efficacy of intravitreal therapy with bevacizumab and ranibizumab for choroidal neovascularization (CNV) in pathologic myopia (PM). METHODS: This was a prospective multicenter randomized nonblinded trial. RESULTS: In seven centers, 78 eyes were randomized 1:1 to treatment with bevacizumab (group B, 40 eyes) or ranibizumab (group R, 38 eyes) given with an "on demand" regimen (PRN). The mean follow-up was 19 months (SD 2, range 12-24). The mean BCVA at baseline was 0.60 logMAR (20/80 Snellen equivalent, Seq) and 50 letter score (ls). Mean final BCVA was 0.51 LogMAR (20/63 Seq) and 57 ls (p = 0.0009 and p = 0.0002, respectively). In group B, mean basal BCVA was…

MaleVascular Endothelial Growth Factor AVisual Acuity/drug effectsVisual acuitygenetic structuresVisual AcuityAngiogenesis Inhibitorslaw.inventionBevacizumab/therapeutic use0302 clinical medicineRandomized controlled triallawMyopiaMedicineProspective StudiesProspective cohort studyPathological myopiaAged 80 and overMiddle AgedSensory SystemsBevacizumabVascular endothelial growth factor AChoroidal neovascularizationIntravitreal InjectionsMyopia DegenerativeFemalemedicine.symptommedicine.drugAdultmedicine.medical_specialtyBevacizumabNeuroscience(all)CNVBevacizumab; CNV; Pathological myopia; Ranibizumab.Antibodies Monoclonal HumanizedRanibizumab/therapeutic use03 medical and health sciencesCellular and Molecular NeuroscienceOphthalmologyRanibizumabVascular Endothelial Growth Factor A/antagonists & inhibitorsHumansAngiogenesis Inhibitors/therapeutic useIntravitreal bevacizumabAgedpathological myopia CNV bevacizumab ranibizumabSettore MED/30 - Malattie Apparato Visivobusiness.industryTherapeutic effectChoroidal Neovascularization/drug therapyeye diseasesChoroidal NeovascularizationOphthalmologyRegimen030221 ophthalmology & optometryMyopia Degenerative/drug therapysense organsRanibizumabbusiness030217 neurology & neurosurgeryFollow-Up StudiesGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
researchProduct

2q13 microdeletion syndrome: Report on a newborn with additional features expanding the phenotype

2021

In this paper we describe an additional newborn patient with craniofacial dysmorphisms, congenital heart disease, hypotonia and a 2q13 deletion of 1.7 Mb, whose clinical and genomic findings are consistent with the diagnosis of 2q13 microdeletion syndrome.

Pediatricsmedicine.medical_specialtyMedicine (General)Heart diseaseCNVgenotype-phenotype correlationR5-920newborngenotype‐phenotype correlationsfollow-upmedicineCraniofacialGenotype-Phenotype Correlationschromosome 2newborn.GeneticsCNVsfollow‐upbusiness.industryRGeneral MedicineMicrodeletion syndromemedicine.diseasePhenotypeHypotoniaMedicinemedicine.symptombusinessClinical Case Reports
researchProduct

Identification of SNPs and copy number variation in goat MC1R and ASIP genes: an association study with coat colour in a few Mediterranean goat breeds

2008

Settore AGR/17 - Zootecnica Generale E Miglioramento GeneticoASIPCNVMC1RgoatSNP
researchProduct

Il neurone autistico: analisi funzionale in silico dei geni coinvolti nelle Copy Number Variants

2009

Settore BIO/13 - Biologia ApplicataGene ontology Autism CNV
researchProduct

Epilessia e disturbi dello spettro autistico: c'è un rischio genetico condiviso ?

2011

Settore BIO/13 - Biologia Applicataautismo CNV epilessia
researchProduct

Perfil genético, epigenético e inmunohistoquímico en los cánceres de mama esporádicos y hereditarios

2016

El cáncer de mama (CM) es una de las principales causas de muerte por cáncer en la mujer en todo el mundo. En la actualidad el CM se entiende como una enfermedad heterogénea que abarca una serie de entidades definidas por sus diferentes características biológicas y comportamientos clínicos. Todo ello ha llevado a la búsqueda de biomarcadores que, a nivel individual o en combinación con otros marcadores (perfiles), ofrezcan a una mayor precisión diagnóstica, en el comportamiento evolutivo y en la predicción de la respuesta terapéutica. El presente estudio considera como mecanismo etiopatogénico de referencia del CM las mutaciones en los genes supresores tumorales BRCA1 y BRCA2, característic…

UNESCO::CIENCIAS MÉDICAS ::Patología::CarcinogénesisinmunohistoquímicamamametilaciónUNESCO::CIENCIAS MÉDICAS ::Patología::Oncologíacnvcancer:CIENCIAS MÉDICAS ::Patología::Carcinogénesis [UNESCO]:CIENCIAS MÉDICAS ::Patología::Oncología [UNESCO]micrornas
researchProduct

Three different approaches to cognitive fatigue in patients with a mild form of multiple sclerosis : objective cognitive, subjective cognitive and ne…

2017

Tämän tutkimuksen tarkoitus oli arvioida kognitiivista uupumusta lievää multippeli skleroosin (MS) muotoa sairastavilla potilailla kolmea eri lähestymistapaa käyttäen: objektiivista kognitiivista, subjektiivista kognitiivista ja neurofysiologista. Objektiivista kognitiivista uupumusta arvioitiin tarkkaavuuden ylläpitoa, reaktionopeutta ja työmuistia mittaavilla tehtävillä. Subjektiivista kognitiivista uupumusta sekä elämänlaatua arvioitiin itsearvioilla. Neurofysiologiset mittaukset käsittivät aivojen sähköiin herätevasteisiin perustuvia observaatioita. Mittareina olivat kontingentti negatiivinen variaatio (CNV) ja P3. Tutkimukseen osallistui 20 MS-tautia sairastavaa ja 20 verrallistettua t…

cognitionkognitioneuropsykologiamittausCNVneurofysiologiaP3elämänlaatuheikentyminenmultiple sclerosiskognitiiviset prosessituupumuspotilaatquality of lifeMS-tautifatigueEEGarviointi
researchProduct

Event related brain potential (ERP) correlates of activation and effort in state regulation among children with attentional problems

2002

contingent negative variationsuorituspyrkimysmotivaatiohäiriötcontinuous performance taskCNVCPTsäätelyP300tilatarkkaavaisuus
researchProduct

SULT1A1 gene deletion in BRCA2-associated male breast cancer: a link between genes and environmental exposures?

2013

SULT1A1, a member of sulfotransferase superfamily, is a drug and hormone metabolizing enzyme involved in the metabolism of a variety of potential mammary carcinogens of endogenous and exogenous origin. Interestingly, the metabolic activity of SULT1A1 can be affected by varia- tions in gene copy number. Male Breast Cancer (MBC) is a rare disease and less investigated disease compared to female BC (FBC). As in FBC, the concurrent effects of genetic risk factors, particularly BRCA2 mutations, increased exposure to estrogens and environmental carcinogens play a relevant role in MBC. By quantitative real-time PCR with TaqMan probes, we investigated the presence of SULT1A1 gene copy number variat…

copy number variations (CNVs)MaleSettore MED/06 - Oncologia MedicaShort Communicationmale breast cancerDiseaseBiologyBreast Neoplasms Malecopy number variations (cnvs); brca2; sult1a1; male breast cancerPathogenesisSULT1A1 GeneSULT1A1 copy number variations (CNVs) BRCA2 male breast cancermedicineHumansGenetic Predisposition to DiseaseCopy-number variationskin and connective tissue diseasesGeneCarcinogenBRCA2 ProteinGeneticsEnvironmental ExposureCell BiologyEnvironmental exposuremedicine.diseaseBRCA2ArylsulfotransferaseMale breast cancerSULT1A1Molecular MedicineFemaleGene Deletion
researchProduct

12q21 Interstitial Deletions: Seven New Syndromic Cases Detected by Array-CGH and Review of the Literature.

2022

Interstitial deletions of the long arm of chromosome 12 are rare, with a dozen patients carrying a deletion in 12q21 being reported. Recently a critical region (CR) has been delimited and could be responsible for the more commonly described clinical features, such as developmental delay/intellectual disability, congenital genitourinary and brain malformations. Other, less frequent, clinical signs do not seem to be correlated to the proposed CR. We present seven new patients harboring non-recurrent deletions ranging from 1 to 18.5 Mb differentially scattered across 12q21. Alongside more common clinical signs, some patients have rarer features such as heart defects, hearing loss, hypotonia an…

dysmorphismsComparative Genomic Hybridization12q21 deletiongenetic counselingcopy number variants (CNVs)DNA Copy Number Variationscongenital anomaliesarray-CGH; 12q21 deletion; copy number variants (CNVs); variation intolerant genes; loss of function; developmental delay/intellectual disability (DD/ID); congenital anomalies; dysmorphisms; genetic counseling; patient management12q21 deletion array-CGH congenital anomalies copy number variants (CNVs) developmental delay/intellectual disability (DD/ID) dysmorphisms genetic counseling loss of function patient management variation intolerant genesdevelopmental delay/intellectual disability (DD/ID)variation intolerant genesloss of functionSettore MED/03 - Genetica MedicaChromosome Structuresarray-CGHIntellectual DisabilityGeneticsHumansChromosome Deletionpatient managementGenetics (clinical)Genes
researchProduct